Literature DB >> 18031251

Toll-like receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease.

I Sabroe1, M K B Whyte.   

Abstract

The neutrophil is a crucial early defence against microbial infection, but neutrophilic inflammation can result in devastating acute and chronic inflammatory diseases. In the lungs, the neutrophil is a principal part of the pathology of the acute respiratory distress syndrome, and its activation may also be of substantial importance in chronic obstructive pulmonary disease and some forms of asthma. Induction of neutrophil recruitment in response to microbial attack requires activation of TLR (Toll-like receptor)-based signalling pathways and the concerted actions of multiple cell types, including sentinel cells such as monocytes and macrophages acting together with tissue cell types such as the epithelium or smooth-muscle cell. The present review describes some of these networks and the resulting potential for their targeting in respiratory disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031251     DOI: 10.1042/BST0351492

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  A brief bout of exercise alters gene expression and distinct gene pathways in peripheral blood mononuclear cells of early- and late-pubertal females.

Authors:  Shlomit Radom-Aizik; Frank Zaldivar; Szu-Yun Leu; Dan M Cooper
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

Review 2.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

Review 3.  Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders.

Authors:  Vera Paschon; Silvia Honda Takada; Juliane Midori Ikebara; Erica Sousa; Reza Raeisossadati; Henning Ulrich; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2015-04-11       Impact factor: 5.590

4.  Lactobacillus plantarum CECT 7315/7316 intake modulates the acute and chronic innate inflammatory response.

Authors:  Gemma Vilahur; Sergi López-Bernal; Sandra Camino; Guiomar Mendieta; Teresa Padró; Lina Badimon
Journal:  Eur J Nutr       Date:  2014-11-19       Impact factor: 5.614

5.  Angiostatin inhibits acute lung injury in a mouse model.

Authors:  Gurpreet K Aulakh; Sarabjeet S Suri; Baljit Singh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

6.  Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.

Authors:  Michael K Showe; Anil Vachani; Andrew V Kossenkov; Malik Yousef; Calen Nichols; Elena V Nikonova; Celia Chang; John Kucharczuk; Bao Tran; Elliot Wakeam; Ting An Yie; David Speicher; William N Rom; Steven Albelda; Louise C Showe
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 7.  Toll-like receptors in neurodegeneration.

Authors:  Eitan Okun; Kathleen J Griffioen; Justin D Lathia; Sung-Chun Tang; Mark P Mattson; Thiruma V Arumugam
Journal:  Brain Res Rev       Date:  2008-09-12

8.  Brief bout of exercise alters gene expression in peripheral blood mononuclear cells of early- and late-pubertal males.

Authors:  Shlomit Radom-Aizik; Frank Zaldivar; Szu-Yun Leu; Dan M Cooper
Journal:  Pediatr Res       Date:  2009-04       Impact factor: 3.756

9.  Innate immune responses are increased in chronic obstructive pulmonary disease.

Authors:  Katherine Joanne Baines; Jodie Louise Simpson; Peter Gerard Gibson
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

10.  Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.

Authors:  David Van Ly; Monique De Pedro; Peter James; Lucy Morgan; Judith L Black; Janette K Burgess; Brian G G Oliver
Journal:  Respir Res       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.